We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News   Jul 14, 2020 | Original story from the University of Michigan

 
Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

Credit: Gerd Altmann, Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Bacterial Enzymes Hijacked To Create Complex Molecules Usually Made by Plants

News

Chemists at Scripps Research have efficiently created three families of complex, oxygen-containing molecules that are normally obtainable only from plants.

READ MORE

MS Drug Blocks HIV Infection and Transmission in Human Immune Cells

News

Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis, may be used to block HIV infection and reduce the latent reservoir.

READ MORE

The Microbiome’s Role in Attacking Cancerous Tumors

News

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE